# Matteo Bassetti

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matteo-bassetti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 52,180 |
| Field | Antibiotic Resistance in Bacteria |
| h-index | 112 |
| i10-index | 569 |
| Last Known Institution | Azienda Ospedaliera S.Maria |
| OpenAlex ID | https://openalex.org/A5039694085 |
| ORCID iD | https://orcid.org/0000-0002-0145-9740 |
| Works | 1,027 |

## Researcher papers

- [Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#](https://scholariq.org/papers/antimicrobial-therapeutic-drug-monitoring-in-critically-ill-adult-patients-a/)
- [European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)](https://scholariq.org/papers/european-society-of-clinical-microbiology-and-infectious-diseases-escmid/)
- [Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy](https://scholariq.org/papers/predictors-of-mortality-in-bloodstream-infections-caused-by-klebsiella/)
- [Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-cefiderocol-or-best-available-therapy-for-the-treatment/)
- [Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data](https://scholariq.org/papers/effectiveness-of-neuraminidase-inhibitors-in-reducing-mortality-in-patients/)
- [Infections caused by KPC-producing <i>Klebsiella pneumoniae</i> : differences in therapy and mortality in a multicentre study](https://scholariq.org/papers/infections-caused-by-kpc-producing-i-klebsiella-pneumoniae-i-differences-in/)
- [Bloodstream infections in critically ill patients: an expert statement](https://scholariq.org/papers/bloodstream-infections-in-critically-ill-patients-an-expert-statement/)
- [Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial](https://scholariq.org/papers/colistin-and-rifampicin-compared-with-colistin-alone-for-the-treatment-of/)
- [Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology](https://scholariq.org/papers/risk-factors-and-outcome-of-pulmonary-aspergillosis-in-critically-ill/)
- [Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)](https://scholariq.org/papers/antimicrobials-a-global-alliance-for-optimizing-their-rational-use-in-intra/)
- [Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM](https://scholariq.org/papers/invasive-fungal-diseases-in-adult-patients-in-intensive-care-unit-fundicu-2024/)
- [Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial](https://scholariq.org/papers/rezafungin-versus-caspofungin-for-treatment-of-candidaemia-and-invasive/)

## Researcher topics

- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Nosocomial Infections in ICU](https://scholariq.org/topics/nosocomial-infections-in-icu/)

## Researcher university

- [Azienda Ospedaliera S.Maria](https://scholariq.org/institutions/azienda-ospedaliera-s-maria/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.